JW Asset Management LLC held its stake in Teligent, Inc. (NASDAQ:TLGT) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,820 shares of the company’s stock at the end of the second quarter. JW Asset Management LLC’s holdings in Teligent were worth $126,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently bought and sold shares of TLGT. Rhumbline Advisers boosted its stake in Teligent by 0.4% in the second quarter. Rhumbline Advisers now owns 49,622 shares of the company’s stock worth $454,000 after buying an additional 200 shares during the last quarter. Teachers Advisors LLC boosted its stake in Teligent by 1.0% in the fourth quarter. Teachers Advisors LLC now owns 65,454 shares of the company’s stock worth $433,000 after buying an additional 648 shares during the last quarter. Wells Fargo & Company MN boosted its stake in Teligent by 3.1% in the first quarter. Wells Fargo & Company MN now owns 45,617 shares of the company’s stock worth $357,000 after buying an additional 1,369 shares during the last quarter. American International Group Inc. boosted its stake in Teligent by 7.1% in the first quarter. American International Group Inc. now owns 25,488 shares of the company’s stock worth $199,000 after buying an additional 1,680 shares during the last quarter. Finally, Bank of America Corp DE boosted its stake in Teligent by 9.1% in the first quarter. Bank of America Corp DE now owns 39,458 shares of the company’s stock worth $307,000 after buying an additional 3,293 shares during the last quarter. 62.88% of the stock is owned by institutional investors.

Shares of Teligent, Inc. (NASDAQ:TLGT) opened at 6.13 on Monday. The firm’s 50-day moving average price is $7.86 and its 200-day moving average price is $7.98. The firm’s market capitalization is $327.29 million. Teligent, Inc. has a 52-week low of $5.74 and a 52-week high of $9.54.

Teligent (NASDAQ:TLGT) last posted its earnings results on Tuesday, August 8th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by $0.04. The firm had revenue of $18.40 million for the quarter, compared to the consensus estimate of $20.11 million. Teligent had a negative net margin of 11.36% and a positive return on equity of 1.49%. The firm’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.02 earnings per share. On average, equities analysts predict that Teligent, Inc. will post $0.07 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “JW Asset Management LLC Continues to Hold Position in Teligent, Inc. (TLGT)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/08/21/jw-asset-management-llc-continues-to-hold-position-in-teligent-inc-tlgt.html.

A number of analysts have weighed in on the company. Canaccord Genuity reaffirmed a “buy” rating and set a $11.00 price objective on shares of Teligent in a research report on Tuesday, August 8th. Roth Capital set a $9.00 price objective on Teligent and gave the stock a “buy” rating in a research report on Wednesday, August 9th. BidaskClub cut Teligent from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Zacks Investment Research cut Teligent from a “hold” rating to a “sell” rating in a research report on Thursday, July 6th. Finally, ValuEngine cut Teligent from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $9.00.

About Teligent

Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.

Want to see what other hedge funds are holding TLGT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teligent, Inc. (NASDAQ:TLGT).

Institutional Ownership by Quarter for Teligent (NASDAQ:TLGT)

Receive News & Stock Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related stocks with our FREE daily email newsletter.